Maxim Group Reiterates Buy Rating on Braiin Limited

Maxim Group maintained its buy rating for Braiin Limited with a $10 target.

Written by EarningsIQ · Published Jun 16, 2026, 2:05 AM EDT · Updated Jun 16, 2026, 2:01 PM EDT

Key Points

Maxim Group reiterated a buy rating for Braiin Limited (BRAI) with a $10 price target on June 15, 2026.
Braiin Limited, trading at $7.64, has a market cap of approximately $1.51 billion and operates in the technology sector.
Morgan Stanley added 2,400 shares of Braiin Limited, while Royal Bank of Canada added 495 shares.

Maxim Group has reiterated its buy rating for Braiin Limited (NasdaqGM:BRAI) with a price target of $10. The announcement was made on June 15, 2026, by analyst Allen Klee. At the time of the report, Braiin Limited's shares were trading at $7.64.

Other Institutional Activity in Braiin Limited

Morgan Stanley grew its holdings by 2,400 shares, ending with 2,400 shares valued at about $16,704. Royal Bank of Canada added 495 shares, bringing its total to 495 shares worth approximately $3,000. Tower Research Capital LLC (TRC) also increased its stake by 3 shares, now holding 3 shares valued at $21.

Braiin Limited Stock Snapshot

Shares of Braiin Limited are trading near $7.64 on the NasdaqGM. The company has a market capitalization of approximately $1.51 billion. It operates with a 52-week low of $4.19 and a high of $33.00. The stock's 50-day moving average is $7.84, while the 200-day moving average is $7.75. Braiin Limited has a current ratio of 0.034 and a quick ratio of 0.026, indicating liquidity challenges.

Analysts Set New Price Targets

On June 15, 2026, Maxim Group initiated coverage with a buy rating and a $10 price target on Braiin Limited. This reflects the firm's positive outlook on the company's future performance.

About Braiin Limited

Braiin Limited is a technology company based in Subiaco, Western Australia. It focuses on enhancing farming productivity through the use of IoT, wireless connectivity, robotics, software, and AI/ML technologies. The company operates in Australia and New Zealand and employs five people. Braiin Limited was incorporated in 2022 and functions as a subsidiary of Northern Revival Acquisition Corporation.

Bottom Line

Maxim Group's reiteration of a buy rating for Braiin Limited suggests confidence in the company's potential. As a technology firm focused on agricultural solutions, Braiin Limited is navigating a challenging market with promising innovations. Investors should note that analyst ratings are forward-looking, while 13F filings and institutional activities are historical and may not reflect the current market conditions.